keine Finanzberatung

COO · Cooper Companies

Contact lenses (CooperVision) and fertility (CooperSurgical)

Risiko 3/10 · LOW-MODERATE RISK · contact-lens stalwart · $69.59 ▼ 1.49%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $69.59
  • Market cap $13.6B
  • P/E (ttm) 58.97
  • Div yield none
  • 52-wk range $58.89 – $89.83
  • Index rank #444 / —

Wichtigste Risiken

  • Fertility segment slowdown on falling birth rates (Shareholders) — MED
  • J&J and Alcon fight for the same daily-lens shelf (Shareholders) — MED
  • FX and tariff exposure on a global manufacturing base (Shareholders) — LOW
  • One-off charges keep GAAP earnings depressed (Shareholders) — LOW

Fazit

Solid medtech at a reasonable forward price; needs the fertility business to stop being a drag.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.